For a patient with bipolar I disorder who is already taking lurasidone (Latuda) 40 mg daily and lamotrigine 300 mg daily and reports anxiety, what medication, other than quetiapine (Seroquel), would be appropriate?

Adjunctive Medication for Anxiety in Bipolar I Disorder

For a bipolar I patient on lurasidone 40 mg and lamotrigine 300 mg daily who complains of anxiety, I recommend adding an SSRI (specifically sertraline or fluoxetine) as adjunctive therapy, ensuring the patient remains on their current mood stabilizers to prevent mood destabilization.

Rationale and Clinical Approach

The patient is already on a reasonable bipolar depression regimen with lurasidone (an atypical antipsychotic approved for bipolar depression) and lamotrigine (a mood stabilizer with maintenance benefits). The anxiety complaint requires careful consideration since it could represent:

• Residual depressive symptoms
• A comorbid anxiety disorder
• Akathisia from lurasidone (important to rule out first)

First: Rule Out Akathisia

Before adding anything, assess whether the anxiety is actually akathisia from lurasidone, which has a higher risk of this side effect compared to other atypical antipsychotics 1. If the patient describes inner restlessness, inability to sit still, or motor restlessness, this is akathisia—not anxiety—and requires dose reduction of lurasidone rather than adding another medication.

If True Anxiety: SSRI as Adjunctive Therapy

SSRIs can be used adjunctively for anxiety in bipolar disorder, but ONLY when the patient is already taking at least one mood stabilizer 2. Your patient meets this criterion with both lurasidone and lamotrigine on board.

The guideline evidence specifically states: "Antidepressants (selective serotonin reuptake inhibitors [SSRIs] or nontricyclics) may be useful adjuncts for depression as long as the patient is also taking at least one mood stabilizer" 2. While this refers to depression, anxiety symptoms in bipolar disorder often overlap with depressive presentations, and SSRIs have established efficacy for anxiety disorders 3.

Critical caveat: Antidepressants may destabilize mood or precipitate mania 2. Monitor closely for:

• Increased energy or decreased need for sleep
• Racing thoughts or pressured speech
• Impulsivity or risk-taking behavior
• Irritability or agitation

If manic symptoms emerge, reduce or discontinue the SSRI immediately.

Alternative: Benzodiazepines (Short-Term Only)

Benzodiazepines can stabilize acute agitation and anxiety associated with bipolar disorder 2. However, they should be used cautiously and short-term only. Consider lorazepam or clonazepam for acute anxiety management while addressing the underlying issue.

Important warning: Benzodiazepines "may cause disinhibition in younger children" 2, though this is less concerning in adults. They also carry risks of dependence and should not be a long-term solution.

What NOT to Do

• Do not use antidepressant monotherapy (not applicable here since mood stabilizers are already in place) 4, 5
• Avoid gabapentin or topiramate—controlled studies have not found them helpful for bipolar disorder 2
• Do not add another atypical antipsychotic unless switching from lurasidone, as polypharmacy with multiple antipsychotics increases side effect burden without clear benefit

Consider Optimizing Current Regimen

Before adding medications, consider:

1. Increase lurasidone dose: The patient is on 40 mg, but lurasidone is effective up to 120 mg daily for bipolar depression 6. Recent evidence shows lurasidone 20-60 mg is effective for bipolar depression with comorbid severe anxiety 7. However, the current 40 mg dose falls within this range, so increasing may not specifically target anxiety.

2. Ensure adequate dosing duration: Lurasidone requires at least 4-6 weeks for full effect 6

3. Address psychosocial factors: While medication is important, ensure the patient has access to psychoeducation and psychosocial interventions 2

Monitoring Requirements

If adding an SSRI:

• Weekly monitoring initially for mood destabilization, suicidal ideation, or manic switch
• Use standardized rating scales for anxiety and mood symptoms
• Monitor for serotonin syndrome (though risk is low with SSRIs alone)
• Assess response after 4-6 weeks of adequate dosing

Continue existing monitoring for lurasidone and lamotrigine per established protocols 2.

Summary Algorithm

1. Rule out akathisia → If present, reduce lurasidone dose
2. If true anxiety → Add SSRI (sertraline or fluoxetine preferred) while maintaining current mood stabilizers
3. Monitor closely for mood destabilization over first 4-6 weeks
4. Consider short-term benzodiazepine for acute symptom relief while SSRI takes effect
5. If anxiety persists despite adequate SSRI trial → Reassess diagnosis and consider switching lurasidone to quetiapine (which has broader anxiolytic properties, though you've excluded it)